Sign up to view this video Join Now Patient Voice, • 9/19/25 How to Accelerate the Adoption of Decentralized Trials for Rare Disease Indications Previous Aligning Trials with Patient-Lived Experiences Next Decentralized by Design: Operationalizing Hybrid Rare Disease Trials You Might Also Like Decentralized by Design: Operationalizing Hybrid Rare Disease Trials Beyond Biotech: The Rise of Nontraditional Sponsors in Rare Disease Trials Opening Keynote: The Evolving Regulatory Environment for Rare Disease Trials Conducting Rare Disease Clinical Trials to Support Market Access and Commercialization Designing Trials with the End in Mind: Building Market Access into Rare Disease Clinical Development
Sign up to view this video Join Now Patient Voice, • 9/19/25 How to Accelerate the Adoption of Decentralized Trials for Rare Disease Indications Previous Aligning Trials with Patient-Lived Experiences Next Decentralized by Design: Operationalizing Hybrid Rare Disease Trials You Might Also Like Decentralized by Design: Operationalizing Hybrid Rare Disease Trials Beyond Biotech: The Rise of Nontraditional Sponsors in Rare Disease Trials Opening Keynote: The Evolving Regulatory Environment for Rare Disease Trials Conducting Rare Disease Clinical Trials to Support Market Access and Commercialization Designing Trials with the End in Mind: Building Market Access into Rare Disease Clinical Development
